Balancing Market Access and Regulatory Requirements

Bringing a clinical product or service to market requires a careful strategy that ensures regulatory approval and value for payers. However, the different demands of regulatory bodies and reimbursement often result in a two-pronged strategy that can create evidence gaps that can slow the process. In a recent podcast, Anna Forsyth, Cytel’s Vice President of Value and Access, makes the case that aligning these two strategies can help streamline evidence generation and decrease total costs. This can be facilitated with new software platforms.

According to Mansha Sachdev of Cytel, “ Modern software solutions can enable both large and small companies to generate the right evidence and efficiently plan their studies. For example, Cytel’s LiveSLR software is a curated library of clinical and payer relevant evidence that is updated in real time. Powerful machines help our experts extract and identify critical evidence for always up-to-date databases and real-time reporting.”

Read more and find the podcast by clicking here.

(Source: Cytel, December 7^th, 2022)